Literature DB >> 17541109

Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression.

Suzanne E Luty1, Janet D Carter, Janice M McKenzie, Alma M Rae, Christopher M A Frampton, Roger T Mulder, Peter R Joyce.   

Abstract

BACKGROUND: Interpersonal psychotherapy and cognitive-behavioural therapy (CBT) are established as effective treatments for major depression. Controversy remains regarding their effectiveness for severe and melancholic depression. AIMS: To compare the efficacy of interpersonal psychotherapy and CBT in people receiving out-patient treatment for depression and to explore response in severe depression (Montgomery-Asberg Depression Rating Scale (MADRS) score above 30), and in melancholic depression.
METHOD: Randomised clinical trial of 177 patients with a principal Axis I diagnosis of major depressive disorder receiving 16 weeks of therapy comprising 8-19 sessions. Primary outcome was improvement in MADRS score from baseline to end of treatment.
RESULTS: There was no difference between the two psychotherapies in the sample as a whole, but CBT was more effective than interpersonal psychotherapy in severe depression, and the response was comparable with that for mild and moder-ate depression. Melancholia did not predict poor response to either psychotherapy.
CONCLUSIONS: Both therapies are equally effective for depression but CBT may be preferred in severe depression.

Entities:  

Mesh:

Year:  2007        PMID: 17541109     DOI: 10.1192/bjp.bp.106.024729

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  27 in total

1.  Can psychotherapists function as their own controls? Meta-analysis of the crossed therapist design in comparative psychotherapy trials.

Authors:  Fredrik Falkenström; John C Markowitz; Hanske Jonker; Björn Philips; Rolf Holmqvist
Journal:  J Clin Psychiatry       Date:  2012-10-30       Impact factor: 4.384

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Authors:  Sagar V Parikh; Lena C Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

3.  Longitudinal effects of cognitive behavioral therapy for depression on the neural correlates of emotion regulation.

Authors:  Harry Rubin-Falcone; Jochen Weber; Ronit Kishon; Kevin Ochsner; Lauren Delaparte; Bruce Doré; Francesca Zanderigo; Maria A Oquendo; J John Mann; Jeffrey M Miller
Journal:  Psychiatry Res Neuroimaging       Date:  2017-11-08       Impact factor: 2.376

Review 4.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Authors:  David J Kupfer; Ellen Frank; Mary L Phillips
Journal:  Lancet       Date:  2011-12-19       Impact factor: 79.321

Review 5.  Interpersonal psychotherapy for depression: a meta-analysis.

Authors:  Pim Cuijpers; Anna S Geraedts; Patricia van Oppen; Gerhard Andersson; John C Markowitz; Annemieke van Straten
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

Review 6.  A review of empirically supported psychological therapies for mood disorders in adults.

Authors:  Steven D Hollon; Kathryn Ponniah
Journal:  Depress Anxiety       Date:  2010-10       Impact factor: 6.505

Review 7.  Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms.

Authors:  Thomas J Spencer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Performance of a Culturally Tailored Cognitive-Behavioral Intervention Integrated in a Public Health Setting to Reduce Risk of Antepartum Depression: A Randomized Controlled Trial.

Authors:  D Elizabeth Jesse; Bradley N Gaynes; Elizabeth B Feldhousen; Edward R Newton; Shelia Bunch; Steven D Hollon
Journal:  J Midwifery Womens Health       Date:  2015-08-10       Impact factor: 2.388

Review 9.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 10.  Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.

Authors:  R C Kessler; H M van Loo; K J Wardenaar; R M Bossarte; L A Brenner; D D Ebert; P de Jonge; A A Nierenberg; A J Rosellini; N A Sampson; R A Schoevers; M A Wilcox; A M Zaslavsky
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-26       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.